Nastorazepide
Modify Date: 2025-08-22 17:02:41
Nastorazepide structure
|
Common Name | Nastorazepide | ||
|---|---|---|---|---|
| CAS Number | 209219-38-5 | Molecular Weight | 520.620 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 742.8±60.0 °C at 760 mmHg | |
| Molecular Formula | C29H36N4O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 403.0±32.9 °C | |
Use of NastorazepideNastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Target：CCK-2in vitro: Z-360 binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells. Check for active clinical trials or closed clinical trials using this agent. in vivo: Z-360 is a novel orally active CCK-2/gastrin receptor antagonist, significantly inhibits the growth of subcutaneous xenografts of human pancreatic tumor cells in mice, and that Z-360 combined with gemcitabine prolonged survival in a pancreatic carcinoma orthotopic xenograft mice. |
| Name | Nastorazepide |
|---|---|
| Synonym | More Synonyms |
| Description | Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Target：CCK-2in vitro: Z-360 binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells. Check for active clinical trials or closed clinical trials using this agent. in vivo: Z-360 is a novel orally active CCK-2/gastrin receptor antagonist, significantly inhibits the growth of subcutaneous xenografts of human pancreatic tumor cells in mice, and that Z-360 combined with gemcitabine prolonged survival in a pancreatic carcinoma orthotopic xenograft mice. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 742.8±60.0 °C at 760 mmHg |
| Molecular Formula | C29H36N4O5 |
| Molecular Weight | 520.620 |
| Flash Point | 403.0±32.9 °C |
| Exact Mass | 520.268555 |
| LogP | 5.23 |
| Vapour Pressure | 0.0±2.6 mmHg at 25°C |
| Index of Refraction | 1.631 |
| Storage condition | 2-8℃ |
| R22TMY97SG |
| Benzoic acid, 3-[[[[(3R)-5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2,3,4,5-tetrahydro-2-oxo-1H-1,5-benzodiazepin-3-yl]amino]carbonyl]amino]- |
| 3-({[(3R)-5-Cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]carbamoyl}amino)benzoic acid |
| nastorazepide |